Venture Leaders Biotech Program 2024 for Startups | Apply Now!

Applications are now being accepted for Venture Leaders Biotech 2024. This program offers entrepreneurs an unparalleled opportunity to accelerate the growth of their startups by immersing them in one of the foremost hubs of technological innovation in the life sciences: Boston.

Venture Leaders Biotech Program 2024 for startups
Venture Leaders Biotech Program 2024 for startups

The Venture Leaders Biotech program, provided free of charge, serves as a unique platform for leading Swiss-based biotech startups to showcase their potential on the global stage while expanding their network in the United States.

During one week in May, selected Venture Leaders will engage with investors and benefit from the expertise and insights of industry veterans, venture capitalists, and peers.

Previous participants in the program include Covagen (acquired by Johnson & Johnson), Redbiotec (partly acquired by Pfizer), KB Medical (acquired by Globus Medical), Simplicity Bio (acquired by Precision for Medicine), AMAL Therapeutics (acquired by Boehringer Ingelheim), and Interax Biotech (secured Seed round with US investors met during the roadshow).


  • Secure your position in the Swiss National Startup Team 2024 and connect with leaders in the industry and international biotech investors in Boston.


  • Open to founding and managing members of biotech-based Swiss startups;
  • Ready to expand business operations in the United States with international investors;
  • Engaged in building a global biotech startup;
  • Must be incorporated before the commencement of the Roadshow.

Application Requirements

  • Register your project and apply for one of the ten seats in the intensive entrepreneurship week training program hosted in global innovation hubs.

Application Deadline

The application deadline is February 26, 2024.

How to Apply

To apply, click here. You can also click here for more information.



Please enter your comment!
Please enter your name here